
2.89 Delayed Data As of Mar 17 | ![]() Today’s Change | 1.85 Today|||52-Week Range 3.10 | -1.37% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Other | MARKET CAP -- |
PharmaCyte Biotech, Inc. 3960 Howard Hughes Parkway Las Vegas Nevada 89169 |
Joshua Nathaniel Silverman | Chairman, President & Chief Executive Officer |
Carlos A. Trujillo | Chief Financial Officer |
José L. Iglesias | Chief Medical Officer |
Lilli Brandtner | Director-Diabetes Program Development |